Fanale D - Search Results

1

Fanale D, Taverna S, Russo A, Bazan V. Fanale D, et al. Adv Exp Med Biol. 2018;1087:109-117. doi: 10.1007/978-981-13-1426-1_9. Adv Exp Med Biol. 2018. PMID: 30259361 Review.

2

The role of Aurora-A inhibitors in cancer therapy.

Agnese V, Bazan V, Fiorentino FP, Fanale D, Badalamenti G, Colucci G, Adamo V, Santini D, Russo A. Agnese V, et al. Among authors: fanale d. Ann Oncol. 2007 Jun;18 Suppl 6:vi47-52. doi: 10.1093/annonc/mdm224. Ann Oncol. 2007. PMID: 17591831 Free article. Review.

3

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

Russo A, Calò V, Bruno L, Schirò V, Agnese V, Cascio S, Foddai E, Fanale D, Rizzo S, Di Gaudio F, Gulotta E, Surmacz E, Di Fede G, Bazan V. Russo A, et al. Among authors: fanale d. Breast Cancer Res Treat. 2009 Jan;113(1):67-70. doi: 10.1007/s10549-008-9906-7. Epub 2008 Jan 29. Breast Cancer Res Treat. 2009. PMID: 18228134

4

Anti-endothelin drugs in solid tumors.

Russo A, Bronte G, Rizzo S, Fanale D, Di Gaudio F, Gebbia N, Bazan V. Russo A, et al. Among authors: fanale d. Expert Opin Emerg Drugs. 2010 Mar;15(1):27-40. doi: 10.1517/14728210903571667. Expert Opin Emerg Drugs. 2010. PMID: 20102289 Free article. Review.

5

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

Rizzo S, Bronte G, Fanale D, Corsini L, Silvestris N, Santini D, Gulotta G, Bazan V, Gebbia N, Fulfaro F, Russo A. Rizzo S, et al. Among authors: fanale d. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S56-61. doi: 10.1016/S0305-7372(10)70021-9. Cancer Treat Rev. 2010. PMID: 21129611 Review.

6

Breast cancer genome-wide association studies: there is strength in numbers.

Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, Russo A. Fanale D, et al. Oncogene. 2012 Apr 26;31(17):2121-8. doi: 10.1038/onc.2011.408. Epub 2011 Sep 26. Oncogene. 2012. PMID: 21996731 Review.

7

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells.

Insalaco L, Di Gaudio F, Terrasi M, Amodeo V, Caruso S, Corsini LR, Fanale D, Margarese N, Santini D, Bazan V, Russo A. Insalaco L, et al. Among authors: fanale d. J Cell Mol Med. 2012 Sep;16(9):2186-95. doi: 10.1111/j.1582-4934.2012.01527.x. J Cell Mol Med. 2012. PMID: 22260151 Free PMC article.

8

The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.

Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A. Corsini LR, et al. Among authors: fanale d. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S103-9. doi: 10.1517/14728222.2011.650632. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443195 Review.

9

Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.

Di Fiore R, Fanale D, Drago-Ferrante R, Chiaradonna F, Giuliano M, De Blasio A, Amodeo V, Corsini LR, Bazan V, Tesoriere G, Vento R, Russo A. Di Fiore R, et al. Among authors: fanale d. J Cell Physiol. 2013 Jun;228(6):1189-201. doi: 10.1002/jcp.24272. J Cell Physiol. 2013. PMID: 23129384 Free article.

10

Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells.

Terrasi M, Bazan V, Caruso S, Insalaco L, Amodeo V, Fanale D, Corsini LR, Contaldo C, Mercanti A, Fiorio E, Lo Re G, Cicero G, Surmacz E, Russo A. Terrasi M, et al. Among authors: fanale d. J Cell Physiol. 2013 Jun;228(6):1368-74. doi: 10.1002/jcp.24295. J Cell Physiol. 2013. PMID: 23254958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page